The blood-brain barrier (BBB) is formed by brain endothelial cells lining the cerebral microvasculature, and is an important mechanism for protecting the brain from fluctuations in plasma composition, and from circulating agents such as neurotransmitters and xenobiotics capable of disturbing neural function. The barrier also plays an important role in the homeostatic regulation of the brain microenvironment necessary for the stable and co-ordinated activity of neurones. The BBB phenotype develops under the influence of associated brain cells, especially astrocytic glia, and consists of more complex tight junctions than in other capillary endothelia, and a number of specific transport and enzyme systems which regulate molecular traffic across the endothelial cells.
penetration across the brain endothelium is effectively confined to transcellular mechanisms. Small lipophilic molecules such as oxygen, CO 2 and ethanol can freely diffuse across the lipid membranes of the endothelium.
Small polar solutes needed for brain function are transported by a number of specific carriers (e.g. GLUT-1 for glucose, L-system carrier L1 for large neutral amino acids such as leucine) and specific carriers meditate the efflux from the CNS of potentially toxic metabolites (e.g. glutamate). P-glycoprotein is an energy-dependent efflux carrier with broad specificity that keeps out more hydrophobic molecules; it has been localized to the luminal brain endothelial membrane, and plays a major role in protecting the brain from xenobiotics. The brain endothelium has lower levels of endocytosis/transcytosis than peripheral capillaries, but has specific systems for receptormediated and adsorptive endocytosis, that can transfer certain peptides and lipoproteins to the brain. The brain endothelium contains a number of enzyme systems that support the protective and detoxifying roles of the BBB, including enzymes such as monoamine oxidase that ensure that central synaptic function is not adversely affected by circulating neuroactive agents. Thus the term 'BBB' covers a number of static and dynamic properties that enable the endothelium to protect and regulate the brain microenvironment (Abbott & Romero, 1996) .
Induction of the BBB phenotype: role of astrocytes
Although a number of the properties listed are expressed to some degree in peripheral capillary endothelium, most of them are up-regulated in brain endothelium to such an extent that they can be identified as 'markers' of BBB phenotype and function.
There is great interest in the mechanism(s) for this upregulation (Bauer & Bauer, 2000) , to understand more completely the normal physiological function of the BBB, and to gain insights into pathological conditions causing loss or breakdown of aspects of BBB, as an important first step in designing effective therapies and treatment strategies.
Anatomical examination of the brain microvasculature shows that the endfeet of astrocytic glia form a lacework of fine lamellae closely apposed to the outer surface of the endothelium (Kacem et al. 1998) (Fig. 1 ).
This close anatomical apposition led to the suggestion that inductive influences from astrocytic glia could be responsible for the development of the specialized BBB phenotype of the brain endothelium (Davson & Oldendorf, 1967) . Early evidence in support of this hypothesis came from grafting experiments in which brain vessels growing into grafts of peripheral tissue became less tight to intravascular tracers, while the relatively leaky vessels of peripheral tissues became tighter on growing into grafts of brain tissue (reviewed in Bauer & Bauer, 2000) . Later studies showed that cultured astrocytes implanted into areas with normally leaky vessels were able to induce tightening of the endothelium, indicating that astrocytes were a major source of the inductive influence from neural tissue (Janzer & Raff, 1997) . However, some grafts of embryonic brain into host brain do not show tight endothelia, and destruction of glia and neurones does not always cause barrier breakdown (Krum et al. 1997) . These studies suggest that successful barrier induction and maintenance depends critically on the local conditions and maturational state, with important implications for therapeutic grafting for repair of the human brain. The situation in brain tumours is complex. Some glioma cells (e.g. C6)
implanted into rat brain become vascularized by leaky vessels (Bauer & Bauer, 2000) , suggesting either a deficit in production of inductive factors by the proliferating glioma cells, or enhanced production of 'permeability factors' that counteract the inductive effects. However, there is no simple way of predicting Fig. 1 Schematic drawing showing some features of the perivascular astrocytic end feet, which form 'rosette'-like structures on the brain capillary surface. This arrangement would be expected to be optimal for two-way induction and communication between the astrocytes and endothelium, while not forming a physical barrier, so preserving free diffusion between the endothelium and the brain parenchyma. Based on Kacem et al. (1998) .
BBB permeability from the neuropathological classification of human tumour type.
More recent studies in animal models have confirmed the progressive appearance of the full BBB phenotype in blood vessels growing into the developing CNS. There are some species differences in the time-course of barrier tightening, and the barrier becomes relatively impermeable to large proteins such as albumin and horseradish peroxidase before it can effectively exclude smaller solutes such as mannitol and ions (Butt et al. 1990; Bauer & Bauer, 2000) . There is also evidence for gradual maturation of BBB transporters, as seen by differences between the embyronic, neonatal and adult transporter phenotype (Braun et al. 1980 ).
In vitro cell culture models have provided a great deal of information about the induction of the BBB phenotype in brain endothelium, and have generally confirmed the key inductive role of astrocytes (Reinhart & Gloor, 1997; Bauer & Bauer, 2000) . Freshly isolated brain endothelial cells and some immortalized brain endothelial cell lines will grow as a flat monolayer on plastic or on porous filter inserts, and will retain aspects of a BBB phenotype, but generally with some loss of full barrier expression (e.g. leakier tight junctions, down-regulation of enzyme and transport systems) (Krämer et al. 2001) . Some of these properties can be up-regulated by co-culture with cells of glial origin, such as primary astrocytes, astrocytic cell lines, or glioma cells. Thus up-regulation of tight junctional proteins and tightness has been clearly demonstrated (Dehouck et al. 1990; Rubin et al. 1991; Rist et al. 1997; Sobue et al. 1999) . Gamma-glutamyl transpeptidase (γ-GTP) is highly expressed in the brain endothelium in situ, and appears to play a role in amino acid transport; expression is lower in primary cultured brain endothelium, but is partly restored in brain endothelium cocultured with glia (El Hafny et al. 1996) . Several specific transport systems are up-regulated in brain endothelial models exposed to glial influence; this has been documented for GLUT-1, the L-system and A-system amino acid carriers, and P-glycoprotein (El Hafny et al. 1997; Bauer & Bauer, 2000) . Interestingly, the multidrugresistance-related protein MRP1, which shows low expression in brain endothelium in situ, shows greater expression in cultured brain endothelium. This could indicate that neighbouring glial cells cause suppression of endothelial MRP1 expression under normal conditions (Regina et al. 1998) . Glial-mediated suppression of some clotting factors (tissue plasminogen activator and anticoagulant thrombomodulin) in brain endothelium has also been shown (Tran et al. 1999) . Expression of transferrin receptor, and transcytotic mechanisms for low-density lipoprotein (LDL) are also up-regulated by astrocytic influence (Dehouck et al. 1994) .
Where tested on other model systems, including endothelial cells from non-brain sources such as human umbilical vein and bovine aorta, and the ECV304 cell line used as a model with a strong endothelial phenotype, induction such as junctional tightening and upregulation of BBB markers can be seen (Hurst & Fritz, 1996; Dolman et al. 1998; Kuchler-Bopp et al. 1999 ).
This suggests that the ability to respond to the glial inductive signals is not confined to brain endothelial cells.
Nature of inductive signals from glia to endothelium
The nature of the glial influence responsible for induction of BBB features has been a subject of debate and experimentation. Some but not all of the inductive effects reported above can be produced by application of conditioned medium taken from growing glial cells, evidence for action of a soluble factor or factors (Hurst & Fritz, 1996; Sobue et al. 1999) . However, induction is 1999), GDNF (Igarashi et al. 1999; Utsumi et al. 2000) , bFGF (Sobue et al. 1999 ), IL-6 and hydrocortisone (Hoheisel et al. 1998) can each mimic particular aspects of the inductive up-regulation or suppression caused by glial cells. Attempts to isolate the inductive influence(s) from glial conditioned medium have been only partially successful. Early studies found induction was associated with large-molecular-weight peptides/ proteins, while recent work using ECV304 cells as assay system found that the inductive influence from C6 glioma behaved like a non-proteinaceous agent of < 1 kDa molecular weight (Ramsohoye & Fritz, 1998 (Rubin et al. 1991; El Hafny et al. 1996; Pekny et al. 1998 ).
In some places in the nervous system, a blood-tissue (Tontsch & Bauer, 1991) , most studies indicate that the predominant influence maintaining the mature BBB is astrocytic.
Inductive influence of brain endothelium on astrocytes
Given the complexity of BBB induction by glial cells, it is clear that close communication between endothelium and glial cells must occur. It is therefore not surprising to find evidence that the endothelial cells have a reciprocal inductive influence on astrocytes (Estrada et al. 1990; Sperri et al. 1997; Wagner & Gardner, 2000) . Thus square (orthogonal) arrays of particles on astrocytic end feet recently identified as sites of aquaporin-4 localization (Rash et al. 1998 ) are upregulated in co-culture with endothelium. The observed up-regulation of γ-GTP in endothelial cells by glia involves a two-way exchange of signals and an extracellular matrix-mediated effect, while the upregulation of alkaline phosphatase in the same system involves only a diffusive signal (Mizuguchi et al. 1997 ).
When endothelial and glial cells are grown together there is a mutual up-regulation of antioxidant enzymes so that the endothelial and glial partnership is better able to deal with oxidative stress, e.g. in hypoxia/ reperfusion injury (Schroeter et al. 1999 ). Co-culturing also leads to reciprocal effects on receptor phenotype.
Recently, leukaemia inhibitory factor (LIF) released by endothelial cells of the optic nerve has been shown to induce astrocytic differentiation (Mi et al. 2001 
Short-term interaction between glia and endothelium
In addition to the long-term processes involved in induction via altered gene expression, glial-endothelial interactions also occur over a shorter time-scale (seconds to minutes), involving receptor-mediated signalling. So far this has been most clearly documented by monitoring intracellular calcium waves, with evidence for a role for ATP as a glial-endothelial signalling molecule (Paemeleire et al. 1999; Paemeleire & Leybaert, 2000) . Such studies have given support to the idea that astrocytes may play a key role in modulating the energy supply to neurones, including the possibility of regulating endothelial transport in a way that supports neuronal function (Magistretti et al. 1999) 
Humoral modulation of brain endothelial permeability
A number of chemical agents have been shown to modulate the permeability of the blood-brain barrier (Table 1 ) (for reviews see Abbott & Revest, 1991; Abbott, 1998 Abbott, , 2000 , and at least some of these may be released by astrocytic glial cells (asterisked in Table 1 ] i is a common factor in tight junction opening (Olesen, 1989; Abbott & Revest, 1991; Abbott, 1998 ] i and activation of phospholipase A2 (Abbott, 2000) . In pial microvessels studied in situ, Sarker et al. (2000) showed that B2 receptor activation resulted in a permeability increase involving generation of free radicals (Fig. 3) .
Activation of cultured brain endothelium by ATP and related nucleotides caused elevation of [Ca 2+ ] i predominantly via P2U (= P2Y 2 ) receptors (Nobles et al. 1995) .
Interestingly, P2Y 1 receptor activation could also be detected in cells grown on a biological matrix (Sipos et al. 2000) (Fig. 4) , evidence that the endothelial receptor phenotype was influenced by its local environment.
Both in situ and in vitro, the receptor-mediated barrier opening to low doses of agonists can be shortlived, reversing on withdrawal of the agent or even before (Butt, 1995; Easton & Abbott, 1997) . This raises the interesting possibility that barrier opening can occur as a well-regulated process under normal physio- 
Source of BBB permeability modulating agents
Since the mechanisms controlling the tight junctions of the brain endothelium are the 'effectors' of BBB permeability modulation, and the chemical agents listed in Table 1 are the substances capable of exerting the modulation, the possible sources of these molecules are of special interest. In some cases, the endothelium is both able to release the agent and respond to it, e.g. endothelin (ET-1), acting on ETA receptors (Chen et al. 2000) , and ATP acting on nucleotide receptors (Sipos et al. 2000) . Under pathological conditions, mast cells and perivascular microglia (resident macrophages of the CNS) may release inflammatory agents close to the endothelium. The cell types capable of mediating physiological responses include the fine nerve terminals of a number of neuronal populations which run close to microvessels and release agents able to influence endothelial function, such as histamine, substance P and glutamate. As indicated above, astrocytes are able to release several humoral agents including glutamate, aspartate, taurine, ATP, ET-1, NO, TNFα, MIP2 and IL-1β (Chen et al. 2000; Ostrow et al. 2000; Wang et al. 2000; Zhang et al. 2000; Kim & Shin, 2001) , although the regulation of this release is not well understood.
Furthermore, in response to some of the agents able Fig. 3 Evidence for a role of free radicals in bradykinin-mediated increase in permeability of rat pial microvessels in situ, measured with a fluorescence technique. A, the free radical scavengers superoxide dismutase (SOD) and catalase (CAT) (each 100 U mL −1 ) applied separately to the brain surface had little effect on the permeability response to 5 µM bradykinin, but completely blocked it when used in combination. B, the lipid peroxidation chain blocker butylatedhydroxytoluene (BHT; 1 mM) also inhibited the permeability response to 5 µM bradykinin. (n.s., not significant; **P < 0.01). From Sarker et al. (2000) , by permission.
to open the BBB, astrocytes can up-regulate and release modulating factors, e.g. bradykinin causes upregulation of astrocytic expression and release of the cytokine interleukin-6 (IL-6) (Schwaninger et al. 1999 
Conclusions
In summary, the development and maintenance of the BBB formed by brain endothelium, and the specializa- (fluorescence ratio) were elicited by 100 µM ATP and several related agonists; evidence for presence of different receptors includes the observed response to UTP (P2Y 2 ) and to 2-MeSATP/ 2-MeSADP/ADP (P2Y 1 ). (b) The response to 2-MeSATP was similar in calcium-free and normal medium, evidence for mediation by a metabotropic rather than ionotropic receptor. From Sipos et al. (2000) , by permission.
